Search the Newsreel

Arrowstreet Capital Limited Partnership Sells 485,105 Shares of The Descartes Systems Group Inc. $DSGX

Arrowstreet Capital Limited Partnership significantly reduced its stake in The Descartes Systems Group Inc. (NASDAQ:DSGX) by 27.8% in the first quarter, selling 485,105 shares. Despite this, other institutional investors have either increased or maintained their positions, with 77.73% of the stock owned by institutions. …

CART|Maplebear Inc|Price:42.210|Chg%:-0.320

This article provides a detailed introduction to Maplebear Inc. (CART), operating as Instacart, highlighting its business model as a grocery technology company in North America. It covers the company's partnerships with retailers, its Instacart Platform offerings, financial data, key executives, and major shareholders. The …

United Carton Industries Company Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026

Maplebear Inc. $CART Stock Holdings Boosted by Renaissance Technologies LLC

RNAC|Cartesian Therapeutics Inc|Price:8.690|Chg%:-0.160

Cartesian Therapeutics Inc. (RNAC) is a clinical-stage company focused on cell therapy for autoimmune diseases, utilizing its proprietary technology to enhance cell function with mRNA molecules. Their lead asset, Descartes-08, a CAR-T therapy, is in Phase 3 clinical development for generalized myasthenia gravis and …

Carter Bankshares Inc (CARE) Shareholder Structure: Major Shareholders & Institutional Holdings

This article details the shareholder structure and institutional holdings of Carter Bankshares Inc (CARE). It lists major institutional shareholders, their respective proportions, and changes in their holdings. The report also categorizes shareholder types and outlines the evolution of institutional shareholding over recent quarters.

Cartesian Therapeutics Inc (RNAC) Risk Assessment: Volatility, Financial Risk & Investment Risk

RNAC|Cartesian Therapeutics Inc|Price:7.780|Chg%:-0.100

Cartesian Therapeutics Inc. (RNAC) is a clinical-stage company focused on cell therapy for autoimmune diseases, utilizing its proprietary technology to enhance cell function with mRNA molecules. Their lead asset, Descartes-08, a CAR-T therapy, is in Phase 3 clinical development for generalized myasthenia gravis and …

TradingKey

This article provides a detailed income statement for Cartesian Therapeutics Inc. (RNAC) data from Q1 FY2015 to Q1 FY2026. The financial data includes total revenue, operating expenses, R&D expenses, operating profit, net income, and basic and diluted earnings per share, along with year-over-year percentage …

The Descartes Systems Group Inc. (DSGX) Q4 2023 Earnings Report - Results, Call & Slides

The Descartes Systems Group Inc. (DSGX) reported its Q4 2023 earnings, beating both EPS and revenue expectations. The company recorded an actual EPS of $0.33 against a consensus of $0.28, and actual revenue of $119.90M, surpassing the expected $118.45M. This represents an 18.56% year-over-year …

Descartes Systems Group Inc (DSGX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

This article details the revenue breakdown for Descartes Systems Group Inc (DSGX) by business segment and geographical region. It shows that Services account for the vast majority of revenue at 92.89%, with Professional services and other making up 6.76%, and License revenue at 0.35%. …

DSGX|Descartes Systems Group Inc|Price:68.180|Chg%:+2.450

Descartes Systems Group Inc. (DSGX) focuses on logistics and supply chain management through on-demand, software-as-a-service (SaaS) solutions. The company's services aim to improve productivity, security, and sustainability for logistics-intensive businesses, offering tools for routing, tracking, compliance, and trade data. As of 2026Q1, the Services …

Macarthur Minerals Limited Revenue Breakdown – ASX:MIO

CRI|Carter's Inc|Price:38.750|Chg%:+1.260

Carter's Inc. (CRI) closed at $38.750, up 3.37%. The company has strong fundamentals and high growth potential, with a fair valuation, ranking 23rd in the Specialty Retailers industry. Analysts currently rate the stock as "Hold" with a target price of $42.667.

Maplebear Inc (CART) Valuation: PE, PB & Fair Value Analysis

This article provides a valuation analysis of Maplebear Inc (CART), highlighting its current valuation score and P/E ratio. Maplebear Inc. has a current valuation score of 5.62, ranking 433 out of 485 in the Software & IT Services industry. Its P/E ratio stands at …

Swiss National Bank Has $20.70 Million Stake in The Descartes Systems Group Inc. $DSGX

Swiss National Bank significantly increased its stake in The Descartes Systems Group Inc. (DSGX) by 27% in Q1 2026, bringing its total holdings to 289,424 shares valued at $20.7 million. Other institutional investors also adjusted their positions, with institutions now owning 77.73% of the …

Descartes Systems Group Inc. Revenue Breakdown – BMV:DSG/N

Descartes Systems Group Inc. (BMV:DSG/N) generated total revenue of 12.73 billion MXN last year, with its Services segment being the top performer contributing 12.09 billion MXN. The United States was the largest geographical contributor, accounting for 8.87 billion MXN of the revenue. This data …

Carter Bankshares, Inc. Revenue Breakdown – NASDAQ:CARE

Carter Bankshares, Inc. (NASDAQ: CARE) generated $153.22 million in revenue last year, primarily from its Banking and Related Activities segment. This represents an increase from $135.82 million in the previous year. The entirety of this revenue was contributed by operations within the United States.

Maplebear Inc (CART) Institutional Confidence

Maplebear Inc (CART) has an institutional shareholding score of 7.00, placing it 139th out of 485 in the Software & IT Services industry. The institutional shareholding proportion is 85.50%, which is an 18.69% decrease quarter-over-quarter. James Simons is the largest institutional shareholder, holding 0.66% …

Enterprise value to EBIT forward of Maplebear Inc. – BMV:CART

This article provides financial information for Maplebear Inc. (BMV:CART), specifically focusing on its enterprise value to EBIT forward. It is presented in the context of TradingView's platform, offering various financial tools and data. The information is sourced from ICE Data Services, FactSet, and Quartr …

Carter Bankshares (NASDAQ:CARE) Reaches New 12-Month High - What's Next?

Carter Bankshares (NASDAQ:CARE) recently hit a new 52-week high of $35.14, closing near $34.99 after a 2.7% daily increase, despite cautious analyst sentiment and a consensus "Hold" rating with an average target price of $28.50. The company reported mixed quarterly results, missing EPS estimates …

Instacart's AI and Advertising Push Could Reshape Its Growth Outlook

Maplebear Inc. CART, doing business as Instacart, is trying to widen its growth model beyond grocery-delivery transaction fees. The strategy leans on artificial intelligence, retail media, enterprise software and real-time store data. These initiatives could improve monetization, but they also add technology costs, partner …

How Instacart Is Expanding Growth Beyond Grocery Delivery Services

Maplebear Inc. CART, doing business as Instacart, is moving beyond its roots as a grocery-delivery marketplace. Its platform now spans enterprise software, retail media, artificial intelligence and connected-store tools. The investor question is whether these businesses can deepen retailer relationships and support more durable …

Is CART Stock Attractive After Strong Growth and Margin Pressure?

Maplebear Inc. CART, doing business as Instacart, presents a balanced investment setup after a quarter that mixed healthy marketplace growth with visible margin pressure. The stock's current valuation partly reflects that tension. CART trades below its own historical sales multiple, but still at a …

Aristides Capital LLC Buys 90,533 Shares of Carter's, Inc. $CRI

Aristides Capital LLC significantly increased its stake in Carter's, Inc. (NYSE:CRI) by purchasing an additional 90,533 shares in Q1, raising its total holdings to 163,949 shares, representing about 0.44% of the company. Carter's recently reported better-than-expected quarterly earnings with EPS of $0.39 and revenue …

The Descartes Systems Group Inc. $DSGX Stake Lessened by Bessemer Group Inc.

Bessemer Group Inc. significantly reduced its stake in The Descartes Systems Group Inc. (NASDAQ:DSGX) by 93.5% in the first quarter, selling over 185,000 shares. Despite this large sale, institutional investors collectively hold a substantial 77.73% of the stock, with firms like Vanguard and Norges …

The Descartes Systems Group Inc. (NASDAQ:DSGX) Given Consensus Recommendation of "Moderate Buy" by Brokerages

The Descartes Systems Group Inc. (NASDAQ:DSGX) has received a "Moderate Buy" consensus rating from analysts, with an average 12-month price target of approximately $102.54. Despite this positive outlook, the stock recently traded down 3.5% at $65.73, near its yearly low and below moving averages. …

ETFs Investing in Cartesian Therapeutics, Inc. Stocks

This article lists ETFs that invest in Cartesian Therapeutics, Inc. stocks, providing details such as market value, weight, issuer, management style, and expense ratio. It highlights three specific ETFs: Janus Henderson Small Cap Growth Alpha ETF (JSML), iShares Microcap ETF (IWC), and Invesco NASDAQ …

Carter Bankshares declares $0.10 quarterly dividend

Carter Bankshares, Inc. (NASDAQ:CARE) has announced a quarterly cash dividend of $0.10 per share. This dividend is payable on August 24, 2026, to shareholders of record as of August 10, 2026, with an annualized yield of 1.22% based on a recent closing stock price. …

Carter’s earnings up next: Can baby apparel momentum hold?

Carter's Inc. (CRI) is scheduled to report its second-quarter earnings, with analysts expecting a significant sequential decline in earnings per share but a modest year-over-year revenue increase. Investors will be closely watching if the company can maintain its strong Q1 U.S. retail momentum, particularly …

Carter Bankshares, Inc. Announces Second Quarter 2026 Financial Results

Carter Bankshares, Inc. announced its financial results for the second quarter of 2026, reporting a net income of $28.9 million, or $1.31 diluted EPS. This compares to $85.8 million, or $3.88 diluted EPS, in the first quarter of 2026 and $8.5 million, or $0.37 …

Carter Bankshares' Insurance Sale Adds $35.9M Gain in Q2

Carter Bankshares reported net income of $28.9 million, or $1.31 diluted EPS, for Q2 2026, significantly bolstered by a $35.9 million pre-tax gain from the sale of its interest in Bearing Insurance Group. This transaction, alongside a prior loan sale, contributed substantially to nonrecurring …

Carter Bankshares, Inc. (CARE) Q2 Earnings and Revenues Top Estimates

Carter Bankshares, Inc. (CARE) reported Q2 earnings of $0.53 per share, exceeding the Zacks Consensus Estimate of $0.41, and revenues of $68.92 million, also surpassing estimates. Despite outperforming the market year-to-date with a 67.5% share increase, the stock currently holds a Zacks Rank #4 …

Carter Bankshares : CARE

Carter Bankshares Inc. (CARE) exceeded Q2 earnings estimates by 24% and revenue estimates by 22.9%, driven by a significant increase in net interest margins. The Martinsville, Virginia-based bank achieved this by restructuring its portfolio, swapping lower-yielding securities for higher-quality assets, and eliminating wholesale borrowing. …

Carter Bank & Trust declares $0.10 dividend

* Carter Bank & Trust (CARE [https://seekingalpha.com/symbol/CARE]) declares $0.10/share quarterly dividend [https://seekingalpha.com/pr/20593171-carter-bankshares-inc-declares-quarterly-dividend], in line with previous. * Forward yield [https://seekingalpha.com/symbol/CARE/dividends/yield?source=news_bullet] 1.22% * Payable Aug. 24; for shareholders of record Aug. 10; ex-div Aug. 10. * See CARE Dividend Scorecard, Yield Chart, & Dividend Growth. …

Carter Bankshares Sets Aug. 24 Cash Payment for Shareholders

Carter Bankshares (NASDAQ: CARE) has declared a quarterly cash dividend of $0.10 per share, approved by its board on July 22, 2026. This dividend, representing an annualized yield of 1.22% based on a closing price of $32.92 on July 22, will be paid on …